Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy-Reference-Cited by-同舟云学术

Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy

Published:2020-12-14 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tsujimoto Hiraku¹,Tsujimoto Yasushi²,Nakata Yukihiko³,Fujii Tomoko⁴,Takahashi Sei²⁵,Akazawa Mai⁶,Kataoka Yuki⁷

Affiliation:

1. Hospital Care Research Unit; Hyogo Prefectural Amagasaki General Medical Center; Hyogo Japan

2. Department of Healthcare Epidemiology; School of Public Health in the Graduate School of Medicine, Kyoto University; Kyoto Japan

3. Department of Mathematics; Shimane University; Matsue Japan

4. Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Australia

5. Center for Innovative Research for Communities and Clinical Excellence (CiRC2LE); Fukushima Medical University; Fukushima Japan

6. Department of Anesthesia; Shiga University of Medical Science Hospital; Otsu Japan

7. Department of Respiratory Medicine; Hyogo Prefectural Amagasaki General Medical Center; Hyogo Japan

Publisher

Wiley

Subject

Pharmacology (medical)

Reference108 articles.

1. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter;Arcangeli;Thrombosis Research,2010

2. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study;Bellomo;Intensive Care Medicine,1993

3. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding [abstract no: TH-FC107];Betjes;Journal of the American Society of Nephrology,2006

4. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding;Betjes;Journal of Nephrology,2007

5. Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study;Birnbaum;Renal Failure,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coagulation Risk Predicting in Anticoagulant-Free Continuous Renal Replacement Therapy;Blood Purification;2024-08-12

2. Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study;BMC Nephrology;2024-02-26

3. Factors affecting continuous renal replacement therapy duration in critically ill patients: A retrospective study;Therapeutic Apheresis and Dialysis;2023-06-12

4. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials;Critical Care;2023-06-07

5. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury;Intensive Care Medicine;2022-09-06